Assessment of the accuracy of disease coding among patients diagnosed with sarcoma
Menée aux Etats-Unis à partir des données des registres d'un centre hospitalier à forte activité et d'un centre de lutte contre le cancer portant au total sur 2 292 patients et à l'aide des classifications internationales CIM-9, CIM-10 et CIM-O-3, cette étude évalue la précision du codage des sarcomes diagnostiqués et caractérise les erreurs de codage commises
The rarity of sarcoma makes performing appropriately powered studies challenging and increases the significance of accurate data collection. Tumor registries and population-based databases are increasingly used to determine sarcoma incidence, treatment patterns, and outcomes.1-3 The utility of these databases is contingent on meticulous data collection. Although the validity of large databases has been questioned,4 little is documented about the initial coding process. This study characterizes inaccuracies in coding practices that result in incorrect sarcoma surgical diagnostic codes and tumor registry data at a high-volume health care center. Identification of coding practice errors has implications for the validity of larger oncology databases.
JAMA Oncology , résumé, 2017